161 related articles for article (PubMed ID: 1850758)
1. Pulmonary and urinary clearance of atrial natriuretic factor in acute congestive heart failure in dogs.
Perrella MA; Margulies KB; Wei CM; Aarhus LL; Heublein DM; Burnett JC
J Clin Invest; 1991 May; 87(5):1649-55. PubMed ID: 1850758
[TBL] [Abstract][Full Text] [Related]
2. Clearance receptor-mediated control of atrial natriuretic factor in experimental congestive heart failure.
Brandt RR; Redfield MM; Aarhus LL; Lewicki JA; Burnett JC
Am J Physiol; 1994 Mar; 266(3 Pt 2):R936-43. PubMed ID: 8160889
[TBL] [Abstract][Full Text] [Related]
3. The role of neutral endopeptidase in dogs with evolving congestive heart failure.
Margulies KB; Barclay PL; Burnett JC
Circulation; 1995 Apr; 91(7):2036-42. PubMed ID: 7895362
[TBL] [Abstract][Full Text] [Related]
4. Biologic role of atrial natriuretic factor clearance receptor in congestive heart failure.
Perrella MA; Aarhus LL; Heublein DM; Lewicki JA; Burnett JC
Am J Physiol; 1993 Jul; 265(1 Pt 2):H401-8. PubMed ID: 8342659
[TBL] [Abstract][Full Text] [Related]
5. Natriuretic and antialdosterone actions of chronic oral NEP inhibition during progressive congestive heart failure.
Martin FL; Stevens TL; Cataliotti A; Schirger JA; Borgeson DD; Redfield MM; Luchner A; Burnett JC
Kidney Int; 2005 May; 67(5):1723-30. PubMed ID: 15840018
[TBL] [Abstract][Full Text] [Related]
6. ANF-mediated renal cGMP generation in congestive heart failure.
Margulies KB; Heublein DM; Perrella MA; Burnett JC
Am J Physiol; 1991 Apr; 260(4 Pt 2):F562-8. PubMed ID: 1849364
[TBL] [Abstract][Full Text] [Related]
7. Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure.
Cavero PG; Margulies KB; Winaver J; Seymour AA; Delaney NG; Burnett JC
Circulation; 1990 Jul; 82(1):196-201. PubMed ID: 2142023
[TBL] [Abstract][Full Text] [Related]
8. Cardiac atrial natriuretic factor during evolution of congestive heart failure.
Perrella MA; Schwab TR; O'Murchu B; Redfield MM; Wei CM; Edwards BS; Burnett JC
Am J Physiol; 1992 Apr; 262(4 Pt 2):H1248-55. PubMed ID: 1373574
[TBL] [Abstract][Full Text] [Related]
9. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.
Kukkonen P; Vuolteenaho O; Ruskoaho H
Endocrinology; 1992 Feb; 130(2):755-65. PubMed ID: 1531129
[TBL] [Abstract][Full Text] [Related]
10. Role of endogenous atrial natriuretic factor in acute congestive heart failure.
Lee ME; Miller WL; Edwards BS; Burnett JC
J Clin Invest; 1989 Dec; 84(6):1962-6. PubMed ID: 2531762
[TBL] [Abstract][Full Text] [Related]
11. Clearance of atrial natriuretic factor by lung, liver, and kidney in human subjects and the dog.
Hollister AS; Rodeheffer RJ; White FJ; Potts JR; Imada T; Inagami T
J Clin Invest; 1989 Feb; 83(2):623-8. PubMed ID: 2521490
[TBL] [Abstract][Full Text] [Related]
12. Atrial natriuretic factor: pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failure.
Moe GW; Canepa-Anson R; Armstrong PW
J Cardiovasc Pharmacol; 1992 May; 19(5):691-700. PubMed ID: 1381766
[TBL] [Abstract][Full Text] [Related]
13. Modulation by atrial natriuretic factor of receptor-mediated cyclic AMP-dependent responses in canine pulmonary artery during heart failure.
Mathew R; Omar HA; Fayngersh R; Shen W; Wang J; Gewitz MH; Hintze TH; Wolin MS
Br J Pharmacol; 1996 Aug; 118(8):1886-90. PubMed ID: 8864519
[TBL] [Abstract][Full Text] [Related]
14. Failure of atrial natriuretic factor to increase with volume expansion in acute and chronic congestive heart failure in the dog.
Redfield MM; Edwards BS; McGoon MD; Heublein DM; Aarhus LL; Burnett JC
Circulation; 1989 Sep; 80(3):651-7. PubMed ID: 2527645
[TBL] [Abstract][Full Text] [Related]
15. Intrarenal effects of ecadotril during acute volume expansion in dogs with congestive heart failure.
Solter P; Sisson D; Thomas W; Goetze L
J Pharmacol Exp Ther; 2000 Jun; 293(3):989-95. PubMed ID: 10869402
[TBL] [Abstract][Full Text] [Related]
16. Atrial natriuretic factor: implications in congestive heart failure and hypertension.
Burnett JC
J Hum Hypertens; 1989 Jun; 3 Suppl 1():41-6. PubMed ID: 2528638
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin inhibition potentiates the renal responses to neutral endopeptidase inhibition in dogs with congestive heart failure.
Margulies KB; Perrella MA; McKinley LJ; Burnett JC
J Clin Invest; 1991 Nov; 88(5):1636-42. PubMed ID: 1658047
[TBL] [Abstract][Full Text] [Related]
18. Neutral endopeptidase inhibition potentiates the renal actions of atrial natriuretic factor.
Margulies KB; Cavero PG; Seymour AA; Delaney NG; Burnett JC
Kidney Int; 1990 Jul; 38(1):67-72. PubMed ID: 2143548
[TBL] [Abstract][Full Text] [Related]
19. Renal response to acute neutral endopeptidase inhibition in mild and severe experimental heart failure.
Chen HH; Schirger JA; Chau WL; Jougasaki M; Lisy O; Redfield MM; Barclay PT; Burnett JC
Circulation; 1999 Dec; 100(24):2443-8. PubMed ID: 10595958
[TBL] [Abstract][Full Text] [Related]
20. Glomerular atrial natriuretic factor receptors in experimental congestive heart failure.
Isnard R; Carayon A; Eurin J; Maistre G; Bouanani N; Barthelemy C; Crozatier B; Komajda M; Legrand JC
Am J Physiol; 1993 Sep; 265(3 Pt 2):H923-8. PubMed ID: 8214128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
